Gene-targeted studies demonstrate that SIGIRR acts as a nonredundant negative regulator in dampening IL-1R and TLR-induced inflammation and tissue damage, including tuberculosis, candidiasis, aspergillosis, Pseudomonas aeruginosa infection and endotoxemia [18, 23, 33, 36, 37]. This evidence concerns the gene IL1R1 and candidiasis.